Topic: early testing issues

FDA's Rushed AI Rollout Faces Major Challenges

The FDA is rapidly adopting AI tools like Elsa, but internal reports highlight flaws, including inaccuracies, raising concerns about reliability for critical tasks. Early testing of Elsa revealed it often produced incorrect or misleading summaries, casting doubt on its readiness for high-...